Kostas Biliouris

Aug 03, 2026

Kostas Biliouris rated OVID as Outperform on Aug 03, 2026, setting a price target of 9. The call has proven timely, with shares rising 12.88% toward the price target of 9.

Jul 31, 2026

On Jul 31, 2026, ALNY was given a Outperform rating by Kostas Biliouris, with a target price of 350. The stock rallied 20.43% after the rating, narrowing the gap to the target of 350 and validating the bullish stance.

May 04, 2026

DSGN received a Outperform rating from Kostas Biliouris on May 04, 2026, aiming for 21. Momentum has favored the Buy call, with shares climbing from 14.8 to 14.8, rewarding those who trusted the recommendation.

Mar 19, 2026

On Mar 19, 2026, Kostas Biliouris published a Outperform outlook on SRPT, with a target of 37. Shares gained 23.24%, underscoring the accuracy of the bullish outlook toward 37.

Mar 12, 2026

Kostas Biliouris on Mar 12, 2026 assigned PRME a Outperform rating, with a price target of 11. The call has struggled to gain traction, with shares losing 10.19%.

Feb 25, 2026

On Feb 25, 2026, Kostas Biliouris reaffirmed PEPG with a Outperform rating, targeting 15. Shares slid 52.81% despite the recommendation, highlighting downside risks.

Jan 28, 2026

KRRO was rated Outperform by Kostas Biliouris on Jan 28, 2026, with a price objective of 22. A bullish response from the market helped close the gap of 8.94 to the target.

Dec 10, 2025

On Dec 10, 2025, Kostas Biliouris initiated coverage on CNTA with a Outperform rating and target of 62. The stock’s climb of 36.96% since the call highlights the foresight in the rating.

Sep 03, 2025

On Sep 03, 2025, IONS was evaluated by Kostas Biliouris, who gave a Outperform rating and target of 70. Investors saw limited payoff as shares fell short of the 70 target.

Mar 12, 2025

RCKT received a Outperform rating from Kostas Biliouris on Mar 12, 2025, aiming for 50. The rating hasn’t played out as hoped, with the stock trading 60.45% below expectations.

Mar 12, 2025

On Mar 12, 2025, Kostas Biliouris published a Outperform outlook on DYN, with a target of 50. Shares gained 49.03%, underscoring the accuracy of the bullish outlook toward 50.

Mar 12, 2025

Kostas Biliouris on Mar 12, 2025 assigned RNA a Outperform rating, with a price target of 72. The call has struggled to gain traction, with shares losing 68.26%.

Mar 04, 2025

On Mar 04, 2025, Kostas Biliouris reaffirmed SLN with a Outperform rating, targeting 25. The recommendation was supported by strong follow-through as the stock rose from 13.31 to 13.31.

Jan 10, 2025

NTLA was rated Outperform by Kostas Biliouris on Jan 10, 2025, with a price objective of 50. A bullish response from the market helped close the gap of 38.07 to the target.

Jan 10, 2025

On Jan 10, 2025, Kostas Biliouris initiated coverage on DTIL with a Outperform rating and target of 34. The stock’s climb of 27.02% since the call highlights the foresight in the rating.

Aug 15, 2024

Kostas Biliouris issued a Outperform recommendation for MGX on Aug 15, 2024, price target set at 17. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Jul 18, 2024

On Jul 18, 2024, FDMT was evaluated by Kostas Biliouris, who gave a Outperform rating and target of 40. Investors saw limited payoff as shares fell short of the 40 target.

Jul 03, 2024

Kostas Biliouris rated LEGN as Outperform on Jul 03, 2024, setting a price target of 90. The stock has underperformed, dropping 58.20% despite the bullish target of 90.